Literature DB >> 16969114

Functional interaction of CREB binding protein (CBP) with nuclear transport proteins and modulation by HDAC inhibitors.

Colm M Ryan1, Janet C Harries, Karin B Kindle, Hilary M Collins, David M Heery.   

Abstract

Nuclear transport proteins such as CSE1, NUP93 and Importin-alpha have recently been shown to be chromatin-associated proteins in yeast, which have unexpected functions in gene regulation. Here we report interactions between the mammalian histone acetyltransferase CBP with nuclear transport proteins CAS (a CSE1 homologue) and Importin-alpha (Impalpha) and NUP93. CAS was found to bind the SRC1 interaction domain (SID) of CBP via a leucine-rich motif in the N-terminus of the protein, that is conserved in other SID-binding proteins. Coimmunoprecipitation experiments also revealed that CBP and Impalpha proteins form a complex. As Impalpha is a known acetylation target of CBP/p300, and is recycled to the cytoplasm via the exportin CAS, we investigated whether HDAC inhibitors would alter the subcellular localization of these proteins. Treatment of COS-1 cells with the HDAC inhibitors trichostatin A or sodium butyrate resulted in sequestration of Impalpha in the nuclear envelope, accumulation of CAS in nuclear aggregates, and an increased number of CBP-containing PML bodies per cell. In addition, HDACi treatment appeared to enhance the association of Impalpha and CBP in coimmunoprecipitation experiments. Our results provide evidence for novel functional interactions between the chromatin modification enzyme CBP and nuclear transport proteins in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969114     DOI: 10.4161/cc.5.18.3207

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  12 in total

1.  Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3.

Authors:  Zi-Jian Wang; Aoife Hanet; Daniel Weishäupl; Inês M Martins; Anna S Sowa; Olaf Riess; Thorsten Schmidt
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

Review 2.  The tale of protein lysine acetylation in the cytoplasm.

Authors:  Karin Sadoul; Jin Wang; Boubou Diagouraga; Saadi Khochbin
Journal:  J Biomed Biotechnol       Date:  2010-11-28

3.  A frustrated binding interface for intrinsically disordered proteins.

Authors:  Per Jemth; Xin Mu; Åke Engström; Jakob Dogan
Journal:  J Biol Chem       Date:  2014-01-13       Impact factor: 5.157

4.  Global histone acetylation induces functional genomic reorganization at mammalian nuclear pore complexes.

Authors:  Christopher R Brown; Caleb J Kennedy; Valerie A Delmar; Douglass J Forbes; Pamela A Silver
Journal:  Genes Dev       Date:  2008-03-01       Impact factor: 11.361

Review 5.  Nuclear neighborhoods and gene expression.

Authors:  Rui Zhao; Megan S Bodnar; David L Spector
Journal:  Curr Opin Genet Dev       Date:  2009-03-30       Impact factor: 5.578

6.  The transition state structure for coupled binding and folding of disordered protein domains.

Authors:  Jakob Dogan; Xin Mu; Åke Engström; Per Jemth
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 7.  Nuclear Periphery Takes Center Stage: The Role of Nuclear Pore Complexes in Cell Identity and Aging.

Authors:  Ukrae H Cho; Martin W Hetzer
Journal:  Neuron       Date:  2020-06-17       Impact factor: 18.688

8.  SUMOylation regulates the nuclear mobility of CREB binding protein and its association with nuclear bodies in live cells.

Authors:  Colm M Ryan; Karin B Kindle; Hilary M Collins; David M Heery
Journal:  Biochem Biophys Res Commun       Date:  2009-12-16       Impact factor: 3.575

Review 9.  Porin new light onto chromatin and nuclear organization.

Authors:  Lee E Finlan; Wendy A Bickmore
Journal:  Genome Biol       Date:  2008-05-16       Impact factor: 13.583

10.  Inhibition of Nuclear Transport of NF-ĸB p65 by the Salmonella Type III Secretion System Effector SpvD.

Authors:  Nathalie Rolhion; R Christopher D Furniss; Grzegorz Grabe; Aindrias Ryan; Mei Liu; Sophie A Matthews; David W Holden
Journal:  PLoS Pathog       Date:  2016-05-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.